🕒 Friday 13 February 2026 Fri, 13 Feb 2026

Truscott Mining has begun its RC drilling program at the Westminster Project, with the ASX confirming no suspension will occur as of mid-February. Investors await assay results expected in the coming months.

Neometals Ltd has resolved a longstanding legal dispute with a $1 million settlement, clearing the way to focus on advancing its Barrambie Gold Project and sustainable processing technologies.

ECP Emerging Growth Limited reported a 6.9% portfolio loss for H1 2025, underperforming the ASX Small Ordinaries Index, yet declared a fully franked interim dividend and teased a significant special dividend.

Bubalus Resources has responded to ASX concerns over a delayed director interest notice, attributing the lapse to an administrative oversight and reaffirming its commitment to compliance.

BTC Health’s investee, BTC Cardio, has landed exclusive Australian distribution rights for Jafron Biomedical’s hemoperfusion cartridges, aiming for a 2026 market debut pending regulatory approval.

Touch Ventures Limited reported a $4.6 million net loss for 2025, driven by investment impairments and foreign exchange impacts, while appointing Gannet Capital as its new investment manager to revamp its portfolio strategy.

WCM Global Growth Limited reported a net operating profit of $22.9 million for H1 FY2026 and announced an increased fully franked interim dividend, reinforcing its progressive dividend policy.

WCM Global Growth Limited reported a 51% drop in net profit for H1 FY2026 but announced an increased fully franked interim dividend, reflecting confidence in its investment strategy. The company’s portfolio outperformed its benchmark over 12 months despite a softer half-year return.

Galilee Energy has launched an offer of up to 464 million new options to participants in its recent $6.5 million placement, aiming to bolster exploration funding and working capital. The options, exercisable at $0.011 each over three years, come amid significant operational and market risks.

Global Uranium and Enrichment Limited has been fully acquired by Snow Lake Resources through a share and option scheme, leading to GUE's imminent delisting from the ASX.

Katana Capital Limited has reported a remarkable 672% increase in half-year profit after tax to $5.8 million, driven by strong investment income and gains. The company maintains its quarterly dividend at 0.5 cents per share, reflecting confidence in its ongoing strategy.

Lithium Energy Limited is set to begin a 2,700-metre drilling campaign at its Sandy Creek Gold-Copper Prospect following rock chip samples revealing significant copper, gold, and silver grades. This marks a key step in exploring the Capricorn Gold-Copper Belt Project near the historic Mt Morgan mine.

Meridian Energy's January 2026 report reveals robust hydro and wind generation fueled by above-average water and snow storage, alongside rising retail sales, despite wholesale electricity prices plummeting to historic lows.

ResMed Inc has updated the foreign exchange rate for its upcoming dividend payment to Australian CDI holders, impacting the Australian dollar amount payable per share. The dividend remains unfranked and subject to US withholding tax, with a reduced rate available under the US-Australia tax treaty.

Advance ZincTek Limited has confirmed a shareholder-approved capital return of 2 cents per share, distributing approximately A$1.252 million back to investors. Payment instructions have been issued ahead of the scheduled February payout.

Ovanti Limited has completed a $1.08 million capital raise through a large share placement aimed at funding its growing U.S. buy now, pay later business and global operations.

Sky Metals Limited has raised $20.5 million through a share placement to accelerate development of its flagship Tallebung Tin Project in NSW, positioning the company for near-term tin production.

BrainChip has launched its AKD2500 silicon development project, advancing its Akida™ 2.0 neuromorphic AI platform with a $2.5 million investment and prototype expected by Q3 2026.

Felix Gold Limited has confirmed significant extensions to gold mineralisation at its NW Array prospect in Alaska's Treasure Creek, with high-grade assay results and broad gold halos around antimony veins. The mineralised system remains open for further expansion, supporting the company's dual-commodity strategy.

AVITA Medical reported a mixed fourth quarter with revenue pressures easing and full-year growth, underpinned by a new $60 million credit facility and advancing clinical trials.

Regal Asian Investments has announced a fully franked interim dividend of 8 cents per share, reflecting robust portfolio returns exceeding 30% over six months. The company also updates its dividend policy to focus on sustainable payouts tied to investment performance.

AVITA Medical closed 2025 with steady revenue growth and over 80% gross margin, setting the stage for a confident revenue forecast of up to US$85 million in 2026. The company also secured a new debt facility with improved terms, underpinning its growth ambitions.

AVITA Medical reported steady Q4 losses amid reimbursement challenges but achieved 11% revenue growth for 2025 and secured a $60 million credit facility to fuel future expansion.

AVITA Medical reported an 11% increase in sales revenue for 2025, driven by deeper market penetration and new product launches, while reducing its net loss by 21%. The company secured a $60 million senior secured credit facility but flagged substantial doubt about its ability to continue as a going concern.